Patent Document ID: 20080085320
Application ID: 11872440
Patent Flag: 0

Claim One:
1. A method for the maintenance, improvement and treatment of cognitive and mental condition and disorder comprising: administering to a subject in need thereof a lipid preparation, wherein said lipid is a glycerophospholipid of formula I: wherein R″ represents a serine moiety, and R and R′, which may be identical or different, independently represent hydrogen or an acyl group, wherein said acyl group is selected from saturated, mono-unsaturated or poly-unsaturated fatty acids (PUFA), particularly long-chain poly-unsaturated fatty acids (LC-PUFA), more preferably omega-3 and/or omega-E acyl groups, wherein said omega-3 and omega-6 are of lecithin from a marine source, and salts thereof, with the proviso that R and R′ cannot simultaneously represent hydrogen, and wherein said LC-PUFA constitute at least 5% (w/w) of total fatty acids content of said preparation, preferably more than 10% (w/w), and particularly 20-50% (w/w) wherein said lipid preparation is a pharmaceutical or nutraceutical composition, or functional food, wherein said subject is an adult and wherein said cognitive and mental condition and disorder is selected from the group consisting of Attention Deficit Hyperactivity Disorder, memory impairment and learning disorders, dementia, Alzheimer's disease, senile dementia, depression, Parkinson's disease, multiple sclerosis, dyslexia, cognitive decline, intensity of brain waves, brain glucose utilization, stress, anxiety, mental and psychiatric disorder, concentration and attention, mood, general cognitive and mental well being, neurological disorder, hormonal disorder, aging, vision disorder and neurodegenerative diseases.